Targets C/enhancer binding protein alpha, inhibiting miR143, which inhibits hexokinase 2. Cell-free expression correlates with the stage and grade of bladder cancer and renal cell carcinoma. The gene discussed is HK2; the disease is urinary bladder cancer.